Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.
S. Tripathy; K.A. Lytle; R.D. Stevens; J.R. Bain; C.B. Newgard; A.S. Greenberg; L.S. Huang; D.B. Jump
(2014) J. Lipid Res. 55: 1448-64

Deficiency of CCAAT/enhancer binding protein-epsilon reduces atherosclerotic lesions in LDLR-/- mice.
R. Okamoto; S. Gery; A.F. Gombart; X. Wang; L.W. Castellani; T. Akagi; S. Chen; M. Arditi; Q. Ho; A.J. Lusis; Q. Li; P. Koeffler
(2014) PLoS ONE 9: e85341

The antibiotic effects of vitamin D.
C. Guo; A.F. Gombart
(2014) Endocr Metab Immune Disord Drug Targets 14: 255-66

Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials.
S. Athinarayanan; R. Wei; M. Zhang; S. Bai; M.G. Traber; K. Yates; O.W. Cummings; J. Molleston; W. Liu; N. Chalasani
(2014) PLoS ONE 9: e95366

Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome.
W.C. Fok; Y. Chen; A. Bokov; Y. Zhang; A.B. Salmon; V. Diaz; M. Javors; W.H. Wood; Y. Zhang; K.G. Becker; V.I. Perez; A. Richardson
(2014) PLoS ONE 9: e83988